Thomas Karl Hoffmann

17.0k citations
460 papers · 13.6k · 3 hit papers · h-index 56

Impact in

Papers in

    • Head and Neck Cancer Studies 58
    • Sinusitis and nasal conditions 23
    • Cancer Immunotherapy and Biomarkers 38

Thomas Karl Hoffmann

435 papers receiving 13.1k citations

Thomas Karl Hoffmann's Hit Papers

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study 2018 · 1.4k citations
1.4k0+6+13Years since publication4008001.2k

Peers

Thomas Karl Hoffmann
Comparison fields: 5 of 162
  • Otorhinolaryngology 1.8k
  • Periodontics 1.1k
  • Genetics 1.6k
  • Immunology 3.1k
  • Oncology 3.5k
Replace John G. Batsakis with:
John G. Batsakis United States
Wayne M. Koch United States
Terrill K. McClanahan United States
Anne Janin France
Lorenzo Cosmi Italy
Elisabeth Bloemena Netherlands
Bernhard Homey Germany
Koji Hashimoto Japan
Fabio Facchetti Italy
Peter J. Polverini United States
Thomas Karl Hoffmann relative to John G. Batsakis United States John G. Batsakis's profile →
Citations per field
00.5×5×10×13.6×
John G. Batsakis · 1×
Citations per year

Countries citing papers authored by Thomas Karl Hoffmann

Since Specialization
Citations

This map shows the geographic impact of Thomas Karl Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Karl Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Karl Hoffmann more than expected).

Fields of papers citing papers by Thomas Karl Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Karl Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Karl Hoffmann. The network helps show where Thomas Karl Hoffmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas Karl Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Karl Hoffmann Line = papers co-authored together Thomas Karl Hoffmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 460 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
Hit paper breakdown →
20181366
2
IL-31: A new link between T cells and pruritus in atopic skin inflammation
Hit paper breakdown →
2006797
3
Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients
Hit paper breakdown →
2017545
4 2010451
5 2007364
6
Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
2002350
7 2010243
8
Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells.
2000205
9 2011203
10 2007202
11 2015172
12 2010144
13 2002138
14 2009128
15
Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck.
2002124
16 2007119
17
Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma.
2001113
18 2001112
19 2017107
20 2000100

About Thomas Karl Hoffmann

Thomas Karl Hoffmann is a scholar working on Otorhinolaryngology, Oncology, Immunology, Genetics and Periodontics, having authored 460 papers that have together received 13.6k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (58 papers), Immunotherapy and Immune Responses (45 papers), Cancer Immunotherapy and Biomarkers (38 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (36 papers), Oral microbiology and periodontitis research (30 papers), Nasal Surgery and Airway Studies (29 papers), Immune Cell Function and Interaction (26 papers) and Sinusitis and nasal conditions (23 papers). The work is most often cited by research in Otorhinolaryngology (1.8k citations), Periodontics (1.1k citations), Genetics (1.6k citations), Immunology (3.1k citations) and Oncology (3.5k citations). Thomas Karl Hoffmann has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Theresa L. Whiteside, Patrick Johannes Schuler, Marie‐Nicole Theodoraki, William E. Gooding, H. Bier, Murat Baş, Jens Greve, Norbert Meidenbauer, Georg Kojda and Grzegorz Dworacki. Their work appears in journals such as European Archives of Oto-Rhino-Laryngology, Journal Of Clinical Periodontology, International Journal of Cancer, Cancers and The Laryngoscope.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact